• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
NVCR

NVCR

NovoCure Limited

NASDAQHealthcareMedical - Instruments & SuppliesJE

USD16.15

+0.33 (+2.09%)

Rating:D+

Company Profile

CEO

Frank Leonard

IPO Date

2015-10-01

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Exchange

NASDAQ

Country

JE

Market Metrics

Open

$15.64

Prev. Close

$15.82

Day Low

$14.85

Day High

$16.17

52W Low

$9.82

52W High

$19.25

Market Cap

$1.87B

Volume

1.69M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBearish

Articles

10

Avg Positive

24.4%

Avg Negative

40.2%

Avg Neutral

35.5%

News Feed

Here's Why Novocure Dipped 19% This Week

The Motley Fool·7/30/2021·↑ positive

Why Novocure Tanked on Thursday

The Motley Fool·7/29/2021·↓ negative

NovoCure Limited (NVCR) CEO Asaf Danziger on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·7/29/2021·↓ negative

NovoCure (NVCR) Reports Q2 Loss, Misses Revenue Estimates

Zacks Investment Research·7/29/2021·↑ positive

Novocure Stock Dips As Q2 Earnings Trail Estimates; Higher Costs Hit Bottom Line

Benzinga·7/29/2021·↓ negative

NovoCure: Q2 Earnings Insights

Benzinga·7/29/2021·↓ negative

Novocure Announces Recipients of 3rd Annual AACR-Novocure Grants for Tumor Treating Fields Research Program

Business Wire·7/15/2021·↑ positive

NVCR Stock Price: $229 Target From Mizuho

Pulse2·7/5/2021·↓ negative

NovoCure: High-Income Options Trade, Bullish Vertical Put Spread

Seeking Alpha·7/2/2021·↑ positive

Why Did Novocure Shares Plunge Today?

Benzinga·7/1/2021·↑ positive